BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 19002973)

  • 1. Advances in animal cell recombinant protein production: GS-NS0 expression system.
    Barnes LM; Bentley CM; Dickson AJ
    Cytotechnology; 2000 Feb; 32(2):109-23. PubMed ID: 19002973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of successful cell line selection in transfected GS-NS0 myeloma cells.
    Barnes LM; Bentley CM; Moy N; Dickson AJ
    Biotechnol Bioeng; 2007 Feb; 96(2):337-48. PubMed ID: 17001634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a cholesterol-independent, non-GS NS0 cell line through chemical treatment and application for high titer antibody production.
    Li J; Gu W; Edmondson DG; Lu C; Vijayasankaran N; Figueroa B; Stevenson D; Ryll T; Li F
    Biotechnol Bioeng; 2012 Jul; 109(7):1685-92. PubMed ID: 22252532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuated glutamine synthetase as a selection marker in CHO cells to efficiently isolate highly productive stable cells for the production of antibodies and other biologics.
    Lin PC; Chan KF; Kiess IA; Tan J; Shahreel W; Wong SY; Song Z
    MAbs; 2019 Jul; 11(5):965-976. PubMed ID: 31043114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methionine sulfoximine supplementation enhances productivity in GS-CHOK1SV cell lines through glutathione biosynthesis.
    Feary M; Racher AJ; Young RJ; Smales CM
    Biotechnol Prog; 2017 Jan; 33(1):17-25. PubMed ID: 27689785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the stability of recombinant protein production in the GS-NS0 expression system.
    Barnes LM; Bentley CM; Dickson AJ
    Biotechnol Bioeng; 2001 May; 73(4):261-70. PubMed ID: 11283909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.
    Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC
    Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant Antibody Production in CHO and NS0 Cells: Differences and Similarities.
    Dhara VG; Naik HM; Majewska NI; Betenbaugh MJ
    BioDrugs; 2018 Dec; 32(6):571-584. PubMed ID: 30499081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation and characterization of cholesterol-independent non-GS NS0 cell lines for production of recombinant antibodies.
    Hartman TE; Sar N; Genereux K; Barritt DS; He Y; Burky JE; Wesson MC; Tso JY; Tsurushita N; Zhou W; Sauer PW
    Biotechnol Bioeng; 2007 Feb; 96(2):294-306. PubMed ID: 16897745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids induce glutamine synthetase in folliculostellate cells of rat pituitary glands in vivo and in vitro.
    Shirasawa N; Yamanouchi H
    J Anat; 1999 May; 194 ( Pt 4)(Pt 4):567-77. PubMed ID: 10445824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superfluous glutamine synthetase activity in Chinese Hamster Ovary cells selected under glutamine limitation is growth limiting in glutamine-replete conditions and can be inhibited by serine.
    Maralingannavar V; Parmar D; Panchagnula V; Gadgil M
    Biotechnol Prog; 2019 Sep; 35(5):e2856. PubMed ID: 31148368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limitations to the development of recombinant human embryonic kidney 293E cells using glutamine synthetase-mediated gene amplification: Methionine sulfoximine resistance.
    Yu DY; Noh SM; Lee GM
    J Biotechnol; 2016 Aug; 231():136-140. PubMed ID: 27288593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of serum-free medium for the production of functionally active humanised monoclonal antibody from NS0 mouse myeloma cells engineered using glutamine synthetase as a selectable marker.
    Keen MJ; Hale C
    Cytotechnology; 1995 Jan; 18(3):207-17. PubMed ID: 22358746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of ammonia and lactate through the coupling of glutamine synthetase selection and downregulation of lactate dehydrogenase-A in CHO cells.
    Noh SM; Park JH; Lim MS; Kim JW; Lee GM
    Appl Microbiol Biotechnol; 2017 Feb; 101(3):1035-1045. PubMed ID: 27704181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. All four Mycobacterium tuberculosis glnA genes encode glutamine synthetase activities but only GlnA1 is abundantly expressed and essential for bacterial homeostasis.
    Harth G; Maslesa-Galić S; Tullius MV; Horwitz MA
    Mol Microbiol; 2005 Nov; 58(4):1157-72. PubMed ID: 16262797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine synthetase gene knockout-human embryonic kidney 293E cells for stable production of monoclonal antibodies.
    Yu DY; Lee SY; Lee GM
    Biotechnol Bioeng; 2018 May; 115(5):1367-1372. PubMed ID: 29359789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of glutamine synthetase selection marker improves product titer and reduces glutamine overflow in Chinese hamster ovary cells.
    Sacco SA; Tuckowski AM; Trenary I; Kraft L; Betenbaugh MJ; Young JD; Smith KD
    Biotechnol Bioeng; 2022 Jul; 119(7):1712-1727. PubMed ID: 35312045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamine synthetase of Streptomyces cattleya: purification and regulation of synthesis.
    Paress PS; Streicher SL
    J Gen Microbiol; 1985 Aug; 131(8):1903-10. PubMed ID: 2865328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker.
    Bebbington CR; Renner G; Thomson S; King D; Abrams D; Yarranton GT
    Biotechnology (N Y); 1992 Feb; 10(2):169-75. PubMed ID: 1369477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Animal-free, Protein-Free and Chemically-Defined Media for NS0 Cell Culture.
    Zhang J; Robinson D
    Cytotechnology; 2005 Jun; 48(1-3):59-74. PubMed ID: 19003032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.